Topics
March 2012 | fellow's Focus
Turning Ideas Into Products
Part 2 of 2 parts. Dealing with companies and taking your idea to market.
Nikolas J.S. London, MD; Andre J. Witkin, MD; and Alok S. Bansal, MD with Emmett T. Cunningham Jr., MD, PHD, MPH; Paul E. Tornambe, MD; and Eugene De Juan Jr., MD
October 28, 2026
Nacuity Pharmaceuticals Doses First Patient in Phase 3 Trial of NPI-001 for the Treatment of RP Associated with Usher Syndrome
October 27, 2026
Glaukos Announces License Agreement with RevOpsis Therapeutics for Retinal Therapy
October 26, 2026
Research Identifies Previously Unrecognized Outflow Pathway
October 22, 2026
FDA Clears Opus Genetics' IND Application for OPGx-RDH12 Gene Therapy in Leber Congenital Amaurosis
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
